Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Escalation Study of PF‑06939999 in Participants With Advanced or Metastatic Solid Tumors.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03854227
Recruitment Status : Recruiting
First Posted : February 26, 2019
Last Update Posted : November 1, 2019
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 27, 2022
Estimated Study Completion Date : July 27, 2022